Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...
Yahoo Finance7d
Cytokinetics, Incorporated (CYTK)
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...
Cytokinetics: Promising Drug Pipeline and Strategic Vision Drive Buy Rating
H.C. Wainwright analyst Joseph Pantginis has reiterated their bullish stance on CYTK stock, giving a Buy rating today.Stay Ahead of the ...
Mena FN11d
Cytokinetics Announces 2025 Corporate Milestones And Vision 2030
Jan. 13, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq ... products across three indications and ten novel molecular entities (NMEs) in our pipeline. Ignition : Achieve broad access and ...